ArticleMedicine2022

Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study.

Waleed Kian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.